5 assets in Gaucher Disease Type II

Therapeutic assets addressing Gaucher Disease Type II, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
ly3884961 Gaucher Disease Type II	Prevail Therapeutics	P1/2	CCC (48)
Prednisone Gaucher Disease Type II	Prevail Therapeutics	P1/2	CCC (48)
Sirolimus Gaucher Disease Type II	Prevail Therapeutics	P1/2	CCC (48)
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Gaucher Disease Type II	University of California, San Francisco	P1	CC (43)
Vgn-R08B Gaucher Disease Type II	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	Early P1	C (39)